Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Parkinson's Disease (EFFACE-PD)
NCT05204641Phase 2Completed
- Sponsor
- Medical University of Warsaw
- Start
- Jan 2022
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Unified Parkinson Disease Rating Scale at 12 months. Started Jan 2022; status: completed.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05204641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05204641.